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Abstract

Proteins exist in a delicate balance between the native and unfolded states,
where thermodynamic stability may be sacrificed to attain the flexibility
required for efficient catalysis, binding, or allosteric control. Partitiondefective 6 (Par-6) regulates the Par polarity complex by transmitting a
GTPase signal through the Cdc42/Rac interaction binding PSD-95/Dlg/ZO-1
(CRIB-PDZ) module that alters PDZ ligand binding. Allosteric activation of the
PDZ is achieved by local rearrangement of the L164 and K165 side chains to
stabilize the interdomain CRIB:PDZ interface and reposition a conserved
element of the ligand binding pocket. However, microsecond to millisecond
dynamics measurements revealed that L164/K165 exchange requires a larger
rearrangement than expected. The margin of thermodynamic stability for the
PDZ domain is modest (∼3 kcal/mol) and further reduced by transient
interactions with the disordered CRIB domain. Measurements of local
structural stability revealed that tertiary contacts within the PDZ are disrupted
by a partial unfolding transition that enables interconversion of the L/K
switch. The unexpected participation of partial PDZ unfolding in the allosteric
mechanism of Par-6 suggests that native-state unfolding may be essential for
the function of other marginally stable proteins.

Introduction
Structural fluctuations in the native state of proteins are
essential for biological function.2 As originally defined by Anfinsen and
understood today, the native state is the most stable, kinetically
accessible conformation.3 From a thermodynamic perspective, internal
picosecond to millisecond dynamics within most globular domains are
viewed as small excursions around the global minimum of the
conformational energy landscape.4-7 However, a protein will populate
all thermodynamically (and kinetically) accessible states according to
the relative free energy of each conformation. The population of
unfolded protein in the native state is usually assumed to be
negligible. This assumption may be perfectly valid when the
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equilibrium population of unfolded protein is small: A protein with
ΔGfold = −5 kcal/mol is 99.97% folded. In contrast, when the free
energy of folding (ΔGfold) is marginal (e.g., −2 kcal/mol), a significant
fraction of the protein is unfolded (3.7%) at equilibrium at 25 °C. It
follows that fluctuations in the native state of a marginally stable
protein may include frequent excursions to the unfolded state, partially
folded states, or specific folding intermediates. Small domains with
unfolding intermediates are less rare than once thought,8-10 and we
speculate that some proteins with a single, marginally stable fold
might sample local minima in the conformational energy landscape to
access structurally related but functionally distinct states.
The PSD-95/Dlg/ZO-1 (PDZ) domain of partition-defective 6
(Par-6) is a prototypical example of an allosteric PDZ for which the
folding landscape is uncharacterized. Par-6 is a modular
scaffold/signaling protein that mediates cell polarity in several
biological contexts.11-14 An adjacent Cdc42/Rac interaction binding
(CRIB) motif combines with the PDZ to form a module (CRIB-PDZ)
that interacts with Cdc42, a small GTPase in the Rho subfamily. We
recently demonstrated that the L164–K165 ‘dipeptide switch’ is the
only apparent conformational change in the PDZ upon Cdc42 binding.11
Rearrangement of the side chains of L164 and K165 increases affinity
for a C-terminal PDZ ligand 10-fold by inserting the K165 side chain
into the peptide binding cleft. In the absence of Cdc42-GTP the L164
side chain points into the PDZ core toward the ligand-binding pocket
and K165 is solvent exposed. In this low-affinity conformation (L164
‘in’/K165 ‘out’) CRIB:PDZ interactions are weak and transient (Figure
1). To date, Par-6 is the only PDZ domain in which the carboxylate
binding pocket is remodeled in order to regulate C-terminal ligand
binding.
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Figure 1. L/K switch governs C-terminal ligand binding affinity in the Par-6 CRIB-PDZ
module. CRIB domain is colored red, PDZ domain is colored gray, and ligand binding
cleft is colored red or green to signify low- or high-affinity state, respectively.

Our previous work suggested that the low- and high-affinity
states of the CRIB-PDZ allosteric switch interconvert rapidly on the
NMR chemical shift time scale.11 In the present study, we sought to
measure the intrinsic rate of the dipeptide switch by 15N relaxation
dispersion. Since switch interconversion scarcely alters PDZ structure
we hypothesized that conformational exchange contributions (Rex)
would be localized to the immediate area of the switch itself. Instead,
we found that dipeptide switching is linked to a domain-wide exchange
event in the PDZ. The presence of unstructured CRIB residues Nterminal to the PDZ destabilizes the native PDZ fold and increases
access to an unfolding intermediate. Our results suggest that partial
unfolding is required for allosteric regulation of the Par-6 CRIB-PDZ
module.

Results
Peptide Binding Flips the L/K Switch in Par-6 CRIB-PDZ
Our previous work suggested that the L/K switch flips when a Cterminal peptide (VKESLV) binds the Par-6 PDZ,11 but this ligandinduced conformational change had not been directly detected. To
monitor the conformational state of the dipeptide switch, we
introduced a cysteine at position 164 within the L/K switch (CRIBPDZL164C) and conjugated a nitroxide radical-containing spin label
(MTSL) to the side chain thiol. We estimated residue-specific
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paramagnetic relaxation enhancement (PRE) effects from 1H–15N HSQC
peak intensities in the absence and presence of VKESLV. Backbone
amides exhibiting MTSL-induced broadening in the apo state are
shown in Figure 2A,B (Table S1). With the exception of two CRIB
residues, PREs fill and surround the PDZ binding pocket, indicating that
the C164 side chain extends into the PDZ ligand binding cleft,
equivalent to the position of L164 in the low-affinity state. Peptide
binding altered the PRE pattern substantially (Figure 2C,D, Table S1).
Significant PREs throughout the CRIB domain and one face of the PDZ
domain describe a new set of contacts with the spin label away from
the peptide binding cleft. For example, peptide binding eliminated all
the PREs in the β2 strand (G173, F174, Y175, I176) observed in the
apo state. Taken together, these data indicate that the C164conjugated spin label evacuates the PDZ core to a solvent exposed
position upon VKESLV binding, consistent with a ligand-induced
rearrangement of the dipeptide switch from the low- to high-affinity
PDZ conformation.11

Figure 2. VKESLV binding flips the L/K switch. PRE data for CRIB-PDZL164C. (A) Blue
spheres indicate broadened residues in the apo state. (B) iPRE (iPRE = 1 – Ipara/Idia) vs
residue number for CRIB-PDZL164C. Residues with significant iPRES values include:
A147 and I148 of the CRIB domain, S168 of the β1–2 loop; G174, F174, Y165, and
I176 of the β2 strand; and V239, N241, S242, and S243 of the α2 helix, and L245 and
I246 of the β6 strand. (C) Yellow spheres indicate broadened residues in VKESLVbound state (VKESLV:CRIB-PDZL164C ratio ≥ 6:1), where blue bars indicate those with
proximity to MTSL attached to C164 side chain. (D) iPRE vs residue number for CRIBPDZL164C and VKESLV:CRIB-PDZL164C, where yellow bars indicate those with proximity
to MTSL attached to C164 side chain. Significant iPREs for the CRIB domain (S135,
S137, I138, H140, D141, V145, A147, I149, D150), β 1 strand (R160, V161), β1–2 loop
(S168, D169, K170, L172), β2–3 hairpin (L200), α1 helix region (E207, S208, T209,
G210, L211, V214), β4–5 region (I219, V221, N222, K229), α2 helix (N241, S242,
S243), and β6 strand (I246) highlight a surface of the PDZ domain distant from the
binding cleft (C,D). C164 is marked by a red sphere in (A,C). Proline residues are
marked with a black asterisk, and residues without a calculated iPRE value are marked
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with a red “x”. A complete list of iPRE by residue for apo and VKESLV-bound states is
located in Table S1.

Internal Motions of the PDZ Reveal Global Exchange
Throughout the Domain
We previously detected conformational exchange broadening in
CRIB-PDZ near the L/K switch11,12 and speculated that the low- and
high-affinity states interconvert rapidly on the NMR chemical shift time
scale. To define the intrinsic rate of L/K switch interconversion, 15N R2
dispersion was measured by (Carr–Purcell–Meiboom–Gill) (CPMG)
experiments.15-17 Because L/K switch flipping appeared to be a minor
structural rearrangement, we expected limited R2 dispersions localized
to the switch region. Instead, significant R2 dispersions (Rex ≥ 1 s–1)
were detected at 32 sites in PDZ156–255 and 47 sites in CRIB-PDZ130–255
distributed across each protein (Figure 3A,B). Twenty-three
significantly exchanging residues were common to both constructs
(Figure 3C), suggesting these domain-wide transitions might be
reporting on the same exchange event.

Figure 3. 15N relaxation dispersion reveals a domain-wide transition in apo PDZ156–255
and CRIB-PDZ130–255. Representative dispersion curves for several sites of (A) PDZ156–
255 and (B) CRIB-PDZ130–255 as well as sites that lack dispersion and possess a flat,
featureless profile as a result. 1/τcp is the effective B1 frequency in the CPMG
experiment. (C) Pink spheres indicate residues with significant μs–ms exchange for
both PDZ156–255 and CRIB-PDZ130–255. Red spheres indicate residues with significant
individual μs–ms exchange and those globally fitted for both PDZ156–255 and CRIBPDZ130–255. Analysis proceeded as described previously.1
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Residues that exhibit similar kex values in a folded domain are
likely to report on a single conformational exchange process.4 To
identify the dominant motional mode in each construct, 15N relaxation
dispersion data were subjected to a global fitting process.17-19 Global
fitting of 11 residues in PDZ156–255 and 16 residues for CRIB-PDZ130–255
yielded a rate (kex) of ∼1600 s–1 for each case (Table S2). Because
these internal motions are in the fast exchange regime, population
ratios (pA, pB) and chemical shift differences (Δω) are not reliable for
direct comparison.17,19 However, similar kex values for PDZ156–255 and
CRIB-PDZ130–255 indicate that the CRIB does not measurably alter
intrinsic conformational exchange kinetics in the PDZ. CRIB-PDZ130–255
residues participating in concerted motion are found adjacent to the
PDZ ligand-binding cleft (169, 174, 177, 232, and 243) near the
CRIB:PDZ interface (161, 162, 243, and 247) and distributed
throughout the PDZ domain (179, 187, 213, 216, and 217 are all >10
Å from the ligand-binding cleft). PDZ156–255 residues participating in
similar motions are located in the PDZ ligand binding cleft (174, 177,
and 235) and throughout the domain (179, 180, 188, 204, 207, and
220), but only one residue (162) is present at the CRIB:PDZ interface.
Six residues (162, 174, 177, 179, 204, and 243) are common to the
globally fitted populations of both constructs, and they cluster in or
adjacent to the ligand-binding cleft of the PDZ, with four of those
located in the β2–3 finger of the domain (Figure 3C). Detected motions
in PDZ156–255 and CRIB-PDZ130–255 are likely to be a similar exchange
event intrinsic to the PDZ and modified by the CRIB domain.

Par-6 PDZ Does Not Unfold by a Simple Two-State
Mechanism
Given the domain-wide nature of detected exchange in PDZ156–
255
and CRIB-PDZ130–255, we speculated that measured kex in the 1600
s–1 range may report on an unfolding transition.20,21 As a result, we
utilized single-jump stopped-flow kinetic folding measurements by
monitoring fluorescence emission of Tyr 175 to determine folding and
unfolding rates for PDZ156–255 and CRIB-PDZ130–255.22,23 In a simple twostate protein folding mechanism, fluorescence-based kinetic folding
curves can be fit to a single exponential, and both arms of the
resultant chevron plot exhibit a linear dependence on denaturant
concentration.24-26 The sum of folding (kf) and unfolding (ku) rate
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constants will be equal to the kex determined from 15N dispersion data
if they report on the same behavior. Both PDZ156–255 and CRIB-PDZ130–
255
kinetic stop-flow chevrons displayed nonlinearity (“chevron
rollover”) in the unfolding arm (Figure 4A), however. Importantly,
estimations of folding rates assuming a simple two-state folding
mechanism yielded rate constants significantly below the measured kex
value (kf + ku = 65 s–1), indicating that global unfolding is far too slow
a process to account for detected exchange in the PDZ.

Figure 4. An intermediate is detectable in Par-6 unfolding. (A) Single-jump stoppedflow chevron plots for CRIB-PDZ130–255 (black diamonds) and PDZ156–255 (gray circles).
Both chevrons display slight rollover in the unfolding arm. Nonlinearly fitted two-state
folding equations are shown with black and gray lines for CRIB-PDZ130–255 and PDZ156–
255, respectively. (B) 1H–2D exchange vs [GnHCl] graph showing CRIB-PDZ130–255
residues. V234, T235, and M237 respond linearly to low [GnHCl], indicating their
proximity to the region disrupted upon formation of the folding intermediate, and are
colored red. All other residues are colored blue.

For Par-6 PDZ, chevron rollover in the unfolding arm is
diagnostic of at least one unfolding intermediate in which the first
transition state (TS1) has a higher energy barrier than the second
(TS2), which is destabilized by addition of denaturant, causing an
alteration in the rate-limiting step of protein unfolding.24,27,28 Earlier
reports indicate that PDZ domains do not fold by a two-state
mechanism, but instead sample at least one high-energy, on-pathway
unfolding intermediate that is a feature of the PDZ domain family,5,28-30
consistent with our findings.
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A Partial Unfolding Intermediate Is Detectable in CRIBPDZ130–255
Unfolding intermediates are detectable in deuterium exchange
experiments serially repeated at increasing levels of denaturant.31,32
Amide protons sensitive to partial unfolding excursions display linear
dependence of ΔGHX on denaturant concentration, whereas unaffected
residues remain resistant to low denaturant levels and local effects
govern their ΔGHX values.31,33 Divergent responses of intermediatesensitive and -insensitive residues persist until denaturant stabilizes
the unfolded state, at which point ΔGHX values cluster at a similar
guanidine-driven global unfolding rate.8,30,34 We measured solvent
exchange in CRIB-PDZ130–255 at 0, 0.1, 0.2, 0.3, and 0.4 M guanidine
HCl at 10 °C. Multiple responses are visible in CRIB-PDZ130–255,
demonstrating the presence of at least one unfolding intermediate
(Figure 4B, Table S4). Residues 234, 235, and 237 display a linear
response to denaturant, whereas 221, 229, 233, 236, and 238 are
insensitive to low levels of guanidine. These data are in agreement
with the chevron rollover detected in kinetic folding measurements and
confirm the presence of an unfolding intermediate in CRIB-PDZ130–255.

Flexible CRIB Destabilizes the PDZ Domain
Previously, we reported a small yet significant decrease of
VKESLV binding affinity upon removal of the CRIB domain,11 and we
speculated that transient CRIB-mediated stabilization of the PDZ
domain and ligand binding pocket was responsible.
We collected native 1H–2D exchange data for PDZ156–255 and
CRIB-PDZ130–255 to monitor the effect of CRIB residues on the PDZ
domain. Strikingly, protection factors were higher on average in
PDZ156–255 than CRIB-PDZ130–255 (log PavePDZ = 1.78, log PaveCRIB-PDZ =
1.36), indicating a more rigid PDZ upon CRIB removal (Figure 5A,B).
Free energies of unfolding (ΔGHX) may be calculated from fitted amide
solvent exchange constants,32,35 and the largest calculated ΔGHX value
from a protein reflects its global unfolding energy.30 ΔGHX values were
higher for PDZ156–255 (ΔGHXPDZ = 3.4 ± 0.2 kcal/mol) than CRIB-PDZ130–
255
(ΔGHXCRIB-PDZ = 2.9 ± 0.5 kcal/mol), suggesting that the CRIB
domain destabilizes the PDZ fold in CRIB-PDZ130–255.
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Figure 5. Par-6 CRIB destabilizes the PDZ. Native 1H–2D exchange data by residue for
(A) CRIB-PDZ130–255 (black bars) and (B) PDZ156–255 (gray bars) at 25 °C. Dashed lines
connect residues that exhibit significant protection factors (log P) for both proteins.
(C) Equilibrium guanidine denaturation measurements with increasing concentrations
of GnHCl. Curves represent fitted functions used to determine ΔGGnHCl. Open circles
represent PDZ156–255 (ΔGunfPDZ = 3.2 ± 0.3 kcal/mol), and black diamonds signify
CRIB-PDZ130–255 (ΔGunfCRIB-PDZ = 2.8 ± 0.4 kcal/mol).

To confirm 1H–2D exchange results, we conducted fluorescencebased (Tyr 175) equilibrium unfolding measurements which showed
that CRIB-PDZ130–255 is significantly less stable than PDZ156–255
(ΔGunfCRIB-PDZ = 2.8 ± 0.4 kcal/mol, ΔGunfPDZ = 3.2 ± 0.3 kcal/mol,
Pcomparison = 0.013) (Figure 5C). A correlation plot comparing free
energies determined from both guanidine equilibrium unfolding and
native deuterium exchange supports this conclusion as well (Figure
S2C). The relatively modest ΔGunf values indicate that the Par-6 PDZ
domain is marginally stable in general and by comparison to other PDZ
domains.24,27,30 Transient CRIB-PDZ interactions which promote
peptide binding (KD, VKESLVCRIB-PDZ = 54 ± 5 μM, KD,VKESLVPDZ = 72 ± 5 μM)
also destabilize the PDZ domain by ∼0.4 kcal/mol, demonstrating a
PDZ destabilizing role for the free CRIB domain in Par-6.
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Par-6 Peptide Binding of the PDZ Domain “Quenches”
Exchange in Par-6 PDZ
In the absence of a peptide ligand, the PDZ domain has a
similar μs–ms exchange profile regardless of whether the flexible CRIB
is present (Figure 3C). Peptide binding drives L/K switch conversion to
the high-affinity position,11 so we measured R2 relaxation dispersions
in the presence of saturating amounts of ligand (VKESLV:protein >
6:1). Nine residues possess significant conformational exchange (Rex ≥
1 s–1) in VKESLV:PDZ156–255 compared to 32 in apo PDZ156–255 (Figure
6A). Five residues with significant dispersions in VKESLV:PDZ156–255
cluster near the CRIB:PDZ interface (157, 161, 212, 247, and 249),
while no significant R2 dispersions were found in the ligand binding
pocket. No residues could be globally fitted in VKESLV:PDZ156–255 due
to dissimilar rate constants, marking a large reduction in domain-wide
exchange relative to apo PDZ156–255. In contrast, the Rex dispersion
profile for VKESLV:CRIB-PDZ130–255 remained similar to CRIB-PDZ130–255
(Figure S1B). Global fitting of a subpopulation of residues sharing
similar individual kex values yielded 15 sites fit to an exchange rate
(kex) of 1800 ± 200 s–1, similar to apo CRIB-PDZ130–255 (Table S3B).

Figure 6. VKESLV binding quenches Rex in PDZ156–255 and CRIB-PDZQ144C/L164C.
Comparison of CPMG-based R2 relaxation dispersion data for apo and VKESLV-bound
PDZ156–255 and CRIB-PDZQ144C/L164C. White spheres represent quenched dispersions for
VKESLV-bound Par-6 relative to apo state, red spheres those that retain dispersions,
and yellow for dispersions detected only in VKESLV:PDZ156–255 are indicated in for (A)
VKESLV:PDZ156–255 and (B) VKESLV:CRIB-PDZQ144C/L164C. Nonexchanging residues are
colored blue. Representative dispersion curves demonstrating reduced Rex upon
VKESLV binding for both where black and white circles represent data for L200 in the
apo and VKESLV-bound state, respectively. Black and white triangles represent data
for V239 in the apo and VKESLV-bound state, respectively. VKESLV:protein ratio is
6:1. Analysis proceeded as described previously.1
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To determine if Rex quenching could be replicated by a stabilized
CRIB domain driving the high-affinity conformation of Par-6, we
measured 15N R2 dispersion on a disulfide-stabilized CRIB-PDZ130–255
(CRIB-PDZQ144C/L164C, PDB entry: 2LC6), characterized previously.11
Only PDZ ligand binding pocket residues 174, 175, and 238 exhibited
significant Rex in VKESLV:CPDZQ144C/L164C (Figure 6B), none of which are
near the CRIB:PDZ interface, diagnostic of a stable CRIB:PDZ
interface. Notably, apo CRIB-PDZQ144C/L164C R2 dispersion
measurements yielded a similar exchange profile to apo PDZ156–255 and
apo CRIB-PDZ130–255 (Figure S2D). In agreement with our findings,
equilibrium unfolding and deuterium exchange data indicate that CRIBPDZQ144C/L164C is markedly more stable (ΔGunf = 5.1 ± 0.1 kcal/mol,
ΔGHX = 4.9 ± 0.1 kcal/mol) than CRIB-PDZ130–255 (Figure S2C).
Therefore, only interactions with a flexible CRIB domain promote
instability in the PDZ domain even when peptide is bound in the PDZ
ligand binding pocket.

Discussion and Conclusions
Allosteric activation of the Par-6 CRIB-PDZ module by Cdc42 is
transmitted to the peptide binding site by a dipeptide switch that
interconverts the side chains of L164 and K165 (Figure 1).11 Liganddependent changes in the pattern of paramagnetic broadening (Figure
2) demonstrated that peptide binding displaces L164 from the
carboxylate binding pocket, thereby switching to the high affinity L164
‘out’/K165 ‘in’ configuration observed in Par-6 crystal structures and
other PDZ domains. We measured 15N relaxation dispersion expecting
conformational exchange effects (Rex) near the L/K switch but instead
found that residues throughout the PDZ domain fluctuate at a common
rate of ∼1600 s–1. The frequency of conformational exchange may be
correlated with dipeptide switch interconversion, but the effects extend
well beyond the β1–2 loop, perhaps representing a domain-wide
process. The estimated rates of global folding and unfolding (Figure 4)
were too slow (kex ∼ 65 s–1) to account for the observed Rex, but
additional measurements helped to identify a structural element within
the PDZ domain that undergoes a concerted millisecond time scale
rearrangement.
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R2 Dispersions in Par-6 PDZ Report on Partial Unfolding
Native 1H–2D exchange data identified a set of residues
protected in both CRIB-PDZ130–255 and PDZ156–255 (K165, I195, L212,
E220, V221, I224, V226, V234, M237, M238, V239, and I246) (Figure
5) which delineate a stable ‘folding core’. This is important for two
reasons: First, we observed widespread Rex throughout the PDZ
domain in all apo states of Par-6, (Figure 2), but careful inspection of
the nonexchanging residues in each apo construct reveals a striking
overlap with the stable PDZ core (Figure 7A). In contrast, exchanging
residues are located in or adjacent to the β1–2 loop, which
encompasses the dipeptide switch, and the long β2–3 hairpin (Figure
3C). Second, two residues in the ‘folding core’ group (V234 and M237)
display a linear dependence of ΔGHX at low guanidine concentrations, a
sign of nearby partial unfolding in the structure (Figure 7B).8,30 This is
consistent with previous reports utilizing ϕ-value analysis to determine
unfolding transition-state compositions of PDZ domains.28 They report
that the final folding barrier (TS2) involves docking of the β2–3 finger
into a folding core that includes the α2 helix. Taken together, our
measurements of Par-6 backbone dynamics and unfolding parameters
are consistent with native-state access to an on-pathway unfolding
intermediate similar to that observed for several other PDZ domains.
Dissociation of the β2–3 finger from the rest of the PDZ core would give
the β1–2 loop additional flexibility and provides an opportunity for
isomerization of the dipeptide switch.
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Figure 7. Segregation of dynamic and stable subdomains suggests a possible mode of
partial PDZ unfolding. (A) Pink spheres indicate residues with Rex ≥ 2 s–1 in CRIBPDZ130–255 and PDZ156–255 and red spheres indicate Rex ≥ 2 s–1 and those residues
globally fit for both. Light-blue and navy spheres indicate residues with detectable
protection factors (the “folding core”), where the latter concurrently lack R2
dispersions. One residue, V239, is colored violet because it has a detectable protection
factor and significant Rex. (B) Schematic of L/K switch isomerization via a partial
unfolding mechanism. Residue L164 is colored green, and K165 is colored purple.
Brackets surrounding two center diagrams represent putative energetically equivalent
states in the folding intermediate state. CRIB domain is colored red.

Cdc42-GTP Activation of the CRIB-PDZ
In the absence of Cdc42-GTP (or a high concentration of peptide
ligand), the CRIB-PDZ module is predominantly in the low-affinity
(L164 ‘in’ /K165 ‘out’) L/K switch configuration. Because Cdc42-GTP
promotes isomerization of the L/K switch, which requires partial PDZ
unfolding, we considered the possibility that the GTPase could also
drive the unfolding process. However, NMR and crystallographic
analysis showed that Cdc42 binds preferentially to the CRIB-PDZ
module in the high-affinity (L164 ‘out’ /K165 ‘in’) conformation;11,12,36
formation of the CRIB:PDZ interface is incompatible with the lowaffinity arrangement. Because Cdc42-GTP binding promotes folding of
the CRIB and stabilizes the CRIB:PDZ interface, it seems unlikely that
the GTPase catalyzes PDZ unfolding. Instead, we propose a model in
which allosteric activation of the Par-6 L/K switch involves
spontaneous partial unfolding of the PDZ domain on microsecond–
millisecond (μs–ms) time scales. In this model, Cdc42-GTP binding
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activates Par-6 by shifting a preexisting CRIB-PDZ conformational
equilibrium toward the high-affinity configuration of the L/K switch.

Marginal Thermodynamic Stability As a Functional
Advantage
Evolutionary pressure tunes proteins for efficient function over
all else, provided that sufficient folding energy is preserved.37 As a
consequence, thermodynamic stability of a protein structure will be
compromised in order to gain functionality, as has been shown in T7
lysozyme.38 This reciprocal relationship between thermodynamic
stability and neofunctionalization was recently demonstrated for
another member of the PDZ family. Smith et al. engineered a PKA
substrate site into the ERBIN PDZ domain but found that efficient
phosphorylation also required other destabilizing mutations.39 The
increase in flexibility, they concluded, was necessary to permit PKA to
seize its target sequence for enzymatic activity.39 We observe a similar
reciprocal stability-function relationship in the Par-6 PDZ, where the
modest margin of folding stability (ΔGunfold = 3.4 kcal/mol) ensures
frequent access to a partially unfolded state for dipeptide switch
interconversion. Attachment of the CRIB domain further destabilizes
the PDZ but increases its affinity for the VKESLV peptide. We conclude
that, in the absence of Cdc42-GTP (or a high concentration of peptide
ligand), transient interactions with the disordered CRIB enhance
peptide ligand binding by selectively destabilizing the low-affinity PDZ
conformation, thereby shifting the L/K switch equilibrium toward the
high-affinity configuration.

Functional Unfolding in the Native State
Protein folding is an equilibrium process, and the unfolded state
is significantly populated (>1%) in a protein of marginal stability
(ΔGunfold < 2.8 kcal/mol) at 25 °C. We speculate that functional
advantages derived from protein destabilization often reflect a
requirement for native-state access to an unfolded region of the
conformational energy landscape. Certain proteins undergo large-scale
unfolding motions to undertake their biological roles. Lymphotactin, a
prototypical ‘metamorphic’ protein, interconverts between a monomer
with the canonical chemokine fold that activates its GPCR target and
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an unrelated all-β dimeric structure that binds extracellular matrix
glycosaminoglycans.40-42 The need for an unfolding transition is
apparent when access to different functional states involves a
reversible global structural rearrangement. However, many proteins
exchange between closely related conformations where native-state
unfolding does not appear necessary. Our results suggest that partial
unfolding of the Par-6 PDZ, perhaps populating an evolutionarily
conserved23,29,30 intermediate, is required for allosteric activation of a
conformational switch that modulates ligand binding affinity. This is a
direct demonstration of allosteric PDZ regulation by an unfolding
transition, and we speculate that native-state unfolding contributes to
the function of many other signaling proteins as well.

Materials and Methods
Mutagenesis, Protein Expression, and Purification
Drosophila melanogaster Par-6 proteins were produced as
previously described.12 CRIB-PDZQ144C/L164C variant purification
proceeded as previously described.11 Creation of the CRIB-PDZL164C
variant utilized QuikChange II Site-Directed Mutagenesis Kit
(Stratagene) and verified by DNA sequencing (Retrogen). All proteins
were expressed and purified as previously described.11,12,43 Final
protein purity was measured as >99% by SDS-PAGE and MALDI-TOF
spectroscopy.

NMR Spectroscopy
NMR experiments were carried out at 25 °C on a Bruker Avance
600 MHz or Bruker Avance III 500 MHz spectrometer equipped with a
TCI CryoProbe. All NMR samples contained 0.75–1.25 mM 15N-labeled
protein and were prepared in 90% H2O/10% D2O containing 20 mM
NaHPO4, 20 mM NaAc pH 5.5, 50 mM NaCl, and 0.05% sodium azide.
NMR data were processed with the NMRPipe software package.44 The
Sparky program45 was used for peak intensity determination and
tabulation.
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Paramagnetic Relaxation Enhancement
PRE experiments proceeded as previously detailed,46 except that
purified 15N CRIB-PDZL164C protein was incubated overnight at 4 °C
with a 5-fold molar excess of MTSL (Toronto Research Chemicals) in a
buffered solution containing 20 mM NaHPO4 pH 7.5, 20 mM NaAc, and
50 mM NaCl, and excess free thiol was removed by desalting column.
Nitroxide radical quenching was accomplished by adding 5 μL of
buffer-matched ascorbic acid solution to paramagnetic samples and
incubating for 12 h at 25 °C to achieve full spin label quenching. 1H–
15
N HSQC NMR spectra were measured before and after ascorbate
quenching to obtain peak intensity values for 15N CRIB-PDZ130–255.
Tabluation of peak intensities from paramagnetic and diamagnetic
spectra allowed determination of paramagnetic relaxation caused
directly by MTSL contact with the C164 side chain. iPRE values were
calculated as

where DF represents the dilution factor upon addition of ascorbic acid.
An iPRE value near 0 indicates a noncontacted residue, and a value
near 1 indicates a backbone amide that makes close, consistent
contact with the MTSL label and reports on full bleaching of the NMR
signal in paramagnetic conditions.

R2 Backbone Dispersion Experiments
Measurements of the transverse relaxation rate constant of 15N
amide nuclei proceeded as previously described.1 Relaxation rate
measurements were performed at 83 (6), 100 (6), 125 (6), 151 (6),
175 (5), 200 (6), 250 (6), 300 (6), 384 (5), and 555 (6) Hz (effective
B1 field frequency). A reference experiment (zero relaxation delay) was
repeated 8 times for a total of 62 measurements per experiment. Data
collection and analysis proceeded as previously described,19 except
that rcCPMG data sets were acquired at 15 and 25 °C at 11.7 and 14.1
T for all apo and VKESLV-bound proteins. VKESLV:protein ratio was
≥6:1 for all bound experiments to ensure full binding.
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Stopped-Flow Experiments for Determining Rates of
GnHCl-Induced Unfolding
Stopped-flow kinetic experiments were performed as previously
detailed.42 All experiments used a final concentration of 25 μM protein
in solution. Curve fitting and data analysis proceeded as previously
described,42 except that 5–10 traces per sample point were averaged
to determine kinetic rate constants. For folding measurements, a 1:1
dilution of buffered protein and GnHCl solution with a matched blank
buffer was used. For unfolding measurements, 1:1 dilution of a
buffered protein solution with a buffered GnHCl solution was used.
Buffered solutions contained 25 mM NaHPO4 pH 5.5, 20 mM NaAc, and
50 mM NaCl. All unfolding experiments were conducted by rapid
mixing with GnHCl at multiple final concentrations (0.3, 0.35, 0.4, 0.5,
0.6, 1.0, 1.5, 2.0, 2.75, 3.0, 3.25, and 3.5 M).

Native 1H–2D Exchange Experiments
Native deuterium exchange experiments were collected as serial
H–15N HSQC spectra immediately following dilution of fully
protonated, lyophilized, and 15N-labeled proteins. Data analysis
proceeded as previously described.32,35 Experimental conditions for all
native exchange took place at pD 5.9, 25 °C. 1H–2D exchange vs
[denaturant] experiments were analyzed as previously detailed,8,30,31
except that all NMR experiments took place at pD 5.9, 10 °C.
Guanidine HCl concentrations used were 0.1, 0.2, 0.3, and 0.4 M.
1

Equilibrium Unfolding Experiments and Determination
of Unfolding Free Energies
Measurements were performed as previously described,42 except
that the excitation wavelength of 274 nm was used with a bandwidth
of 6 nm for tyrosine fluorescence. All proteins displayed a λmax at 304
± 2 nm. Buffered (20 mM Na2HPO4, 20 NaAc pH 5.5, 50 mM NaCl)
guanidine HCl stocks were used for all unfolding measurements.
Unfolding curves were recorded by monitoring fluorescence intensity at
304 nm as a function of guanidine concentration. Data analysis
proceeded as previously detailed.42
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